BWAY - BrainsWay Ltd.
About BrainsWay Ltd. (https://www.brainsway.com)
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Hadar Levy | Chief Executive Officer | 1974 | $542,495 USD |
| Michael Cohen | Vice President of US Sales | – | $397,438 USD |
| Colleen Hanlon | Vice President of Medical Affairs | 1980 | $327,488 USD |
| Ido Marom | Chief Financial Officer | 1976 | $303,199 USD |
| Yiftach Roth | Founder & Chief Scientific Officer | 1971 | $108,000 USD |
| Abraham Zangen | Co-Founder, Member of Scientific Advisory Board & Director | 1970 | $69,921 USD |
| David Zacut | Co-Founder & Vice-Chairman | 1953 | $40,246 USD |
| Dor Hagai | Vice President of Operations | – | – |
| Gilead Moiseyev | Chief Technology Officer | 1972 | – |
| Menachem C. Klein | Vice President, General Counsel & Corporate Secretary | – | – |
| Naomi Rozenfeld | Chief Marketing Officer | 1985 | – |